White's group has recently demonstrated that, once autophagy is systemically depleted in a mouse model with conditional whole-body Atg7 deficiency or when autophagy-proficient melanoma cells are subcutaneously injected into mice, melanoma growth significantly slows down (Figure 1B) (68). Here, ATG7 is linked to melanoma.